Phosphatonins: a new class of phosphate-regulating proteins

被引:36
作者
Schiavi, SC
Moe, OW
机构
[1] Genzyme Corp, Appl Genome, Framingham, MA 01701 USA
[2] Dept Vet Affairs Med Ctr, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA
关键词
phosphatonins; fibroblast growth factor 23; frizzled-related protein 4; phosphaturic;
D O I
10.1097/00041552-200207000-00009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review There is an intimate relationship between phosphate and calcium homeostasis throughout the animal kingdom. One traditional assumption is that all phosphate-regulating hormones are primarily calcium-regulating hormones. Although the notion of a circulating substance dedicated to phosphate homeostasis has existed for more than a decade, it is not until recently that these hormones have been identified. The molecular characterization of these substances will prove to be critical for understanding phosphate physiology and clinical disorders of phosphate metabolism. Recent findings This review will focus primarily on the first two proteins recently shown to have phosphatonin properties. Using three human diseases as models and a combination of positional cloning and differential gene expression, fibroblast growth factor 23 and frizzled-related protein 4 were shown to be associated with one or more of these diseases. Although both of these substances have phosphaturic action, their biological effects are likely to extend beyond epithelial phosphate transport. Summary The phosphatonins are a growing family of substances that may act on multiple organs in autocrine, paracrine, and endocrine modes to regulate phosphate metabolism. As this list expands, the need for a more rigid definition of the term phosphatonin becomes evident. The identification and characterization of these phosphate-regulatory compounds will provide a clearer understanding of how individual phosphatonins regulate phosphate in normal and disease physiology.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 72 条
  • [1] Abu-Jawdeh G, 1999, LAB INVEST, V79, P439
  • [2] Characterization of PHEX endopeptidase catalytic activity:: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors
    Boileau, G
    Tenenhouse, HS
    DesGroseillers, L
    Crine, P
    [J]. BIOCHEMICAL JOURNAL, 2001, 355 (03) : 707 - 713
  • [3] Bowe A. E., 2001, Journal of the American Society of Nephrology, V12, p750A
  • [4] FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate
    Bowe, AE
    Finnegan, R
    de Beur, SMJ
    Cho, J
    Levine, MA
    Kumar, R
    Schiavi, SC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (04) : 977 - 981
  • [5] INHIBITION OF RENAL PHOSPHATE-TRANSPORT BY A TUMOR PRODUCT IN A PATIENT WITH ONCOGENIC OSTEOMALACIA
    CAI, Q
    HODGSON, SF
    KAO, PC
    LENNON, VA
    KLEE, GG
    ZINSMIESTER, AR
    KUMAR, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) : 1645 - 1649
  • [6] Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia
    Collins, MT
    Chebli, C
    Jones, J
    Kushner, H
    Consugar, M
    Rinaldo, P
    Wientroub, S
    Bianco, P
    Robey, PG
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (05) : 806 - 813
  • [7] Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains
    Dann, CE
    Hsieh, JC
    Rattner, A
    Sharma, D
    Nathans, J
    Leahy, DJ
    [J]. NATURE, 2001, 412 (6842) : 86 - 90
  • [8] de Beur SMJ, 2001, J BONE MINER RES, V16, pS151
  • [9] Immunolocalization of stanniocalcin in human kidney
    De Niu, P
    Olsen, HS
    Gentz, R
    Wagner, GF
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 137 (02) : 155 - 159
  • [10] DEBEUR SMJ, 2002, IN PRESS J BONE MINE, V17